|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 333/12 |
| (11) | Patento numeris | 3170815 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15822421.2 |
| Europos patento paraiškos padavimo data | 2015-06-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/081952 |
| Data | 2015-06-19 |
| (87) | Numeris | WO 2016/008351 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 201410344963 | 2014-07-18 | CN |
| (72) |
LIAO, Wenjing, CN
GUO, Xiaowen, CN
HUANG, Luning, CN
GU, Eric, CN
|
| (73) |
Zhejiang Huahai Pharmaceutical Co., Ltd,
Xunqiao Linhai, Taizhou, Zhejiang 317024,
CN
Shanghai Syncores Technologies Inc. Ltd., 538 Cailun Road Zhangjiang Hi-Tech Park Pudong New District, Shanghai 201203, CN |
| (54) | METHOD FOR PREPARING CANAGLIFLOZIN INTERMEDIATE 2-(2-METHYL-5-BROMOBENZYL)-5-(4-FLUOROPHENYL)THIOPHENE |
| METHOD FOR PREPARING CANAGLIFLOZIN INTERMEDIATE 2-(2-METHYL-5-BROMOBENZYL)-5-(4-FLUOROPHENYL)THIOPHENE |